$1.150
-0.109 (-9.45%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
SBFM Prediction & Forecast by Similar Chart Analysis
Alphio's SBFM stock price prediction model matches the current Sunshine Biopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.14 (-0.92%). The 1-week path is $1.12 (-2.81%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Sunshine Biopharma Inc Stock?
Sunshine Biopharma Inc (SBFM) appears to be a good buy right now due to its recent surge in stock price by 66% following drug approval and a reverse stock split, indicating strong market optimism. The current price is $1.15, and despite a year-to-date decline of 91.02%, the projected final change based on historical patterns suggests a potential upside of 121.43%. However, the main risk is the negative earnings per share (EPS) of -1.15 reported in the last earnings, which reflects ongoing financial challenges.
SBFM stock price ended at $1.15 on Friday, after losing -9.45%
Sunshine Biopharma Inc (SBFM) last closed at $1.15, losing -9.45%. These facts feed the 1-day and 1-week SBFM price prediction above.
Forecast Drivers
Sunshine Biopharma Inc (SBFM) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches SBFM, ranked by similarity.
Seasonality analysis for SBFM
Historically the probability of a positive August return for SBFM is 0.00%. January offers the highest probability of a positive month at 13.11%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for SBFM
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $1.03 | $1.64 | $2.26 | +42.46% |
| Sep 2026 | $1.69 | $2.29 | $2.45 | +98.94% |
| Oct 2026 | $1.95 | $2.29 | $2.36 | +98.94% |
| Nov 2026 | $1.93 | $1.97 | $2.45 | +71.51% |
| Dec 2026 | $1.86 | $1.88 | $1.99 | +63.06% |
In 2026, Sunshine Biopharma Inc (SBFM) is projected to range from $1.03 to $2.45.
Sunshine Biopharma Inc 2026 monthly forecast
In Aug 2026, Sunshine Biopharma Inc is projected to average $1.64, with a low of $1.03 and high of $2.26.
In Sep 2026, Sunshine Biopharma Inc is projected to average $2.29, with a low of $1.69 and high of $2.45.
In Oct 2026, Sunshine Biopharma Inc is projected to average $2.29, with a low of $1.95 and high of $2.36.
In Nov 2026, Sunshine Biopharma Inc is projected to average $1.97, with a low of $1.93 and high of $2.45.
In Dec 2026, Sunshine Biopharma Inc is projected to average $1.88, with a low of $1.86 and high of $1.99.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.